| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | 3.81e-05 | 562 | 46 | 8 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 6.53e-05 | 303 | 46 | 6 | GO:0003713 | |
| GeneOntologyMolecularFunction | retinoic acid-responsive element binding | 1.08e-04 | 7 | 46 | 2 | GO:0044323 | |
| GeneOntologyMolecularFunction | pre-mRNA binding | 4.32e-04 | 64 | 46 | 3 | GO:0036002 | |
| GeneOntologyMolecularFunction | pre-mRNA intronic binding | 4.64e-04 | 14 | 46 | 2 | GO:0097157 | |
| GeneOntologyMolecularFunction | SMAD binding | 1.02e-03 | 86 | 46 | 3 | GO:0046332 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.15e-03 | 1160 | 46 | 9 | GO:0030674 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.41e-03 | 739 | 46 | 7 | GO:0003682 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.86e-03 | 1244 | 46 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 2.16e-03 | 1271 | 46 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | beta-catenin binding | 2.66e-03 | 120 | 46 | 3 | GO:0008013 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 3.12e-03 | 127 | 46 | 3 | GO:0008094 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 3.28e-03 | 37 | 46 | 2 | GO:0043425 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 3.28e-03 | 37 | 46 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 3.35e-03 | 1356 | 46 | 9 | GO:0060090 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 3.63e-03 | 134 | 46 | 3 | GO:0003697 | |
| GeneOntologyMolecularFunction | zinc ion binding | 4.02e-03 | 891 | 46 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 5.42e-03 | 1459 | 46 | 9 | GO:0000977 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.11e-06 | 526 | 43 | 9 | GO:0007389 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.20e-05 | 144 | 43 | 5 | GO:0045582 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | CDK8 TCF4 SMARCA2 SOX18 ZMIZ1 SSBP4 SSBP3 TCF7L1 EP300 NR2F1 RXRG MEIS1 | 1.81e-05 | 1390 | 43 | 12 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 2.12e-05 | 162 | 43 | 5 | GO:0045621 | |
| GeneOntologyBiologicalProcess | embryo development | ERBB4 SHROOM3 CELF4 COL12A1 SEC24C SOX18 ZMIZ1 SSBP3 ARID1A TCF7L1 EP300 MEIS1 | 2.52e-05 | 1437 | 43 | 12 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 2.97e-05 | 29 | 43 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 3.36e-05 | 88 | 43 | 4 | GO:0006289 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 9.15e-05 | 42 | 43 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 1.04e-04 | 226 | 43 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 1.05e-04 | 44 | 43 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 1.43e-04 | 242 | 43 | 5 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 1.43e-04 | 242 | 43 | 5 | GO:1903708 | |
| GeneOntologyBiologicalProcess | positive regulation of cell-cell adhesion | 1.46e-04 | 389 | 43 | 6 | GO:0022409 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 1.64e-04 | 51 | 43 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 1.77e-04 | 579 | 43 | 7 | GO:0045785 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 1.94e-04 | 54 | 43 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 2.22e-04 | 266 | 43 | 5 | GO:0045619 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA repair | 2.22e-04 | 143 | 43 | 4 | GO:0045739 | |
| GeneOntologyBiologicalProcess | steroid hormone receptor signaling pathway | 3.01e-04 | 155 | 43 | 4 | GO:0043401 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 3.30e-04 | 290 | 43 | 5 | GO:0050870 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TCF4 NACC2 TLE2 YLPM1 SMARCA2 SOX18 ARID1A TCF7L1 EP300 NR2F1 | 4.85e-04 | 1399 | 43 | 10 | GO:0045892 |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte cell-cell adhesion | 4.95e-04 | 317 | 43 | 5 | GO:1903039 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | 4.96e-04 | 906 | 43 | 8 | GO:0043009 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TCF4 NACC2 TLE2 YLPM1 SMARCA2 SOX18 ARID1A TCF7L1 EP300 NR2F1 | 5.25e-04 | 1413 | 43 | 10 | GO:1902679 |
| GeneOntologyBiologicalProcess | head development | 5.45e-04 | 919 | 43 | 8 | GO:0060322 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 5.76e-04 | 78 | 43 | 3 | GO:2000036 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | 5.85e-04 | 929 | 43 | 8 | GO:0009792 | |
| GeneOntologyBiologicalProcess | nuclear receptor-mediated signaling pathway | 8.17e-04 | 202 | 43 | 4 | GO:0141193 | |
| GeneOntologyBiologicalProcess | regulation of hemopoiesis | 8.38e-04 | 540 | 43 | 6 | GO:1903706 | |
| GeneOntologyBiologicalProcess | heart development | 8.88e-04 | 757 | 43 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | embryonic pattern specification | 9.02e-04 | 91 | 43 | 3 | GO:0009880 | |
| GeneOntologyBiologicalProcess | regulation of myoblast differentiation | 9.31e-04 | 92 | 43 | 3 | GO:0045661 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 9.55e-04 | 22 | 43 | 2 | GO:0006337 | |
| GeneOntologyBiologicalProcess | regulation of mitotic metaphase/anaphase transition | 1.02e-03 | 95 | 43 | 3 | GO:0030071 | |
| GeneOntologyBiologicalProcess | positive regulation of double-strand break repair | 1.02e-03 | 95 | 43 | 3 | GO:2000781 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 1.03e-03 | 1269 | 43 | 9 | GO:0009887 | |
| GeneOntologyBiologicalProcess | regulation of metaphase/anaphase transition of cell cycle | 1.12e-03 | 98 | 43 | 3 | GO:1902099 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 1.14e-03 | 24 | 43 | 2 | GO:0032986 | |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 1.14e-03 | 221 | 43 | 4 | GO:0035051 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.15e-03 | 382 | 43 | 5 | GO:0030217 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of mitotic cell cycle | 1.19e-03 | 100 | 43 | 3 | GO:0007091 | |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte activation | 1.19e-03 | 385 | 43 | 5 | GO:0051251 | |
| GeneOntologyBiologicalProcess | regulation of cell-cell adhesion | 1.21e-03 | 580 | 43 | 6 | GO:0022407 | |
| GeneOntologyBiologicalProcess | metaphase/anaphase transition of cell cycle | 1.29e-03 | 103 | 43 | 3 | GO:0044784 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | 1.32e-03 | 1053 | 43 | 8 | GO:0000122 | |
| GeneOntologyBiologicalProcess | megakaryocyte development | 1.34e-03 | 26 | 43 | 2 | GO:0035855 | |
| GeneOntologyBiologicalProcess | regulation of DNA repair | 1.41e-03 | 234 | 43 | 4 | GO:0006282 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | 1.42e-03 | 598 | 43 | 6 | GO:0080135 | |
| GeneOntologyBiologicalProcess | late endosome to vacuole transport via multivesicular body sorting pathway | 1.44e-03 | 27 | 43 | 2 | GO:0032511 | |
| GeneOntologyBiologicalProcess | cellular response to steroid hormone stimulus | 1.52e-03 | 239 | 43 | 4 | GO:0071383 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA splicing, via spliceosome | 1.55e-03 | 28 | 43 | 2 | GO:0048025 | |
| GeneOntologyBiologicalProcess | regulation of sister chromatid segregation | 1.60e-03 | 111 | 43 | 3 | GO:0033045 | |
| GeneOntologyBiologicalProcess | hormone-mediated signaling pathway | 1.64e-03 | 244 | 43 | 4 | GO:0009755 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA processing | 1.66e-03 | 29 | 43 | 2 | GO:0050686 | |
| GeneOntologyBiologicalProcess | intracellular receptor signaling pathway | 1.67e-03 | 416 | 43 | 5 | GO:0030522 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 1.77e-03 | 115 | 43 | 3 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte activation | 1.80e-03 | 423 | 43 | 5 | GO:0002696 | |
| GeneOntologyBiologicalProcess | brain development | 1.84e-03 | 859 | 43 | 7 | GO:0007420 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte differentiation | 1.91e-03 | 429 | 43 | 5 | GO:1902105 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA splicing | 2.15e-03 | 33 | 43 | 2 | GO:0033119 | |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 2.25e-03 | 266 | 43 | 4 | GO:0033044 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte cell-cell adhesion | 2.28e-03 | 447 | 43 | 5 | GO:1903037 | |
| GeneOntologyBiologicalProcess | positive regulation of cell activation | 2.33e-03 | 449 | 43 | 5 | GO:0050867 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 2.42e-03 | 35 | 43 | 2 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 2.42e-03 | 35 | 43 | 2 | GO:0030511 | |
| GeneOntologyBiologicalProcess | circulatory system development | 2.51e-03 | 1442 | 43 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | regulation of T cell activation | 2.54e-03 | 458 | 43 | 5 | GO:0050863 | |
| GeneOntologyCellularComponent | bBAF complex | 9.63e-07 | 10 | 43 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | brahma complex | 2.90e-06 | 14 | 43 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | transcription regulator complex | 2.50e-05 | 596 | 43 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 3.17e-05 | 30 | 43 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | chromatin | TCF4 NACC2 SMARCA2 SOX18 SMARCD2 ZMIZ1 ARID1A TCF7L1 EP300 RXRG MEIS1 | 1.50e-04 | 1480 | 43 | 11 | GO:0000785 |
| GeneOntologyCellularComponent | beta-catenin-TCF complex | 3.18e-04 | 13 | 43 | 2 | GO:1990907 | |
| GeneOntologyCellularComponent | npBAF complex | 3.70e-04 | 14 | 43 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 4.87e-04 | 16 | 43 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.01e-03 | 96 | 43 | 3 | GO:0070603 | |
| GeneOntologyCellularComponent | inhibitory synapse | 1.85e-03 | 31 | 43 | 2 | GO:0060077 | |
| GeneOntologyCellularComponent | ATPase complex | 2.37e-03 | 129 | 43 | 3 | GO:1904949 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 3.38e-03 | 42 | 43 | 2 | GO:0070971 | |
| MousePheno | absent myocardial trabeculae | 2.14e-05 | 22 | 35 | 3 | MP:0000293 | |
| MousePheno | embryonic lethality during organogenesis | ERBB4 UBR4 PTPN23 ZMIZ1 SSBP3 ARID1A TCF7L1 EP300 MEIS1 RNF111 | 3.86e-05 | 876 | 35 | 10 | MP:0006207 |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | 4.10e-05 | 700 | 35 | 9 | MP:0011098 | |
| MousePheno | perinatal lethality, complete penetrance | 4.68e-05 | 712 | 35 | 9 | MP:0011089 | |
| MousePheno | perinatal lethality | TCF4 SHROOM3 CELF4 COL12A1 FUBP1 UBR4 SOX18 ARID1A TCF7L1 EP300 NR2F1 | 6.23e-05 | 1130 | 35 | 11 | MP:0002081 |
| MousePheno | abnormal prenatal growth/weight/body size | CDK8 CELF4 FUBP1 UBR4 YLPM1 PTPN23 ZMIZ1 SSBP3 ARID1A TCF7L1 EP300 NR2F1 | 1.68e-04 | 1493 | 35 | 12 | MP:0004196 |
| MousePheno | decreased hippocampus volume | 3.30e-04 | 11 | 35 | 2 | MP:0020083 | |
| MousePheno | abnormal embryo development | CDK8 SHROOM3 UBR4 YLPM1 PTPN23 SSBP3 ARID1A TCF7L1 EP300 NR2F1 RNF111 | 3.49e-04 | 1370 | 35 | 11 | MP:0001672 |
| MousePheno | absent trabeculae carneae | 4.67e-04 | 13 | 35 | 2 | MP:0000296 | |
| MousePheno | thin placenta labyrinth | 5.44e-04 | 14 | 35 | 2 | MP:0011523 | |
| MousePheno | decreased thigmotaxis | 5.69e-04 | 275 | 35 | 5 | MP:0020870 | |
| MousePheno | neonatal lethality | 6.51e-04 | 799 | 35 | 8 | MP:0002058 | |
| MousePheno | abnormal cardiovascular development | 6.67e-04 | 802 | 35 | 8 | MP:0002925 | |
| MousePheno | abnormal nervous system development | CDK8 TCF4 ERBB4 SHROOM3 SSBP3 ARID1A TCF7L1 EP300 NR2F1 RNF111 | 7.55e-04 | 1257 | 35 | 10 | MP:0003861 |
| MousePheno | decreased brain size | 7.81e-04 | 295 | 35 | 5 | MP:0000774 | |
| MousePheno | decreased anxiety-related response | 8.09e-04 | 452 | 35 | 6 | MP:0001364 | |
| MousePheno | lethality during fetal growth through weaning, complete penetrance | TCF4 SHROOM3 FUBP1 UBR4 SOX18 ARID1A TCF7L1 EP300 NR2F1 MEIS1 | 8.13e-04 | 1269 | 35 | 10 | MP:0011111 |
| MousePheno | abnormal blood circulation | 9.41e-04 | 845 | 35 | 8 | MP:0002128 | |
| MousePheno | abnormal embryonic growth/weight/body size | CDK8 UBR4 YLPM1 PTPN23 ZMIZ1 SSBP3 ARID1A TCF7L1 EP300 NR2F1 | 9.53e-04 | 1295 | 35 | 10 | MP:0002088 |
| Domain | SSDP_DNA-bd | 1.48e-05 | 3 | 42 | 2 | IPR008116 | |
| Domain | Bromodomain_CS | 1.55e-03 | 26 | 42 | 2 | IPR018359 | |
| Domain | LisH | 1.80e-03 | 28 | 42 | 2 | IPR006594 | |
| Domain | LisH | 1.80e-03 | 28 | 42 | 2 | SM00667 | |
| Domain | LISH | 1.80e-03 | 28 | 42 | 2 | PS50896 | |
| Domain | BROMODOMAIN_1 | 3.13e-03 | 37 | 42 | 2 | PS00633 | |
| Domain | Bromodomain | 3.30e-03 | 38 | 42 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 3.83e-03 | 41 | 42 | 2 | PS50014 | |
| Domain | BROMO | 4.02e-03 | 42 | 42 | 2 | SM00297 | |
| Domain | Bromodomain | 4.02e-03 | 42 | 42 | 2 | IPR001487 | |
| Domain | - | 4.02e-03 | 42 | 42 | 2 | 1.20.920.10 | |
| Domain | zf-C4 | 4.80e-03 | 46 | 42 | 2 | PF00105 | |
| Domain | NUCLEAR_REC_DBD_1 | 4.80e-03 | 46 | 42 | 2 | PS00031 | |
| Domain | Znf_hrmn_rcpt | 4.80e-03 | 46 | 42 | 2 | IPR001628 | |
| Domain | Nuclear_hrmn_rcpt | 4.80e-03 | 46 | 42 | 2 | IPR001723 | |
| Domain | ZnF_C4 | 4.80e-03 | 46 | 42 | 2 | SM00399 | |
| Domain | NUCLEAR_REC_DBD_2 | 4.80e-03 | 46 | 42 | 2 | PS51030 | |
| Domain | - | 5.01e-03 | 47 | 42 | 2 | 1.10.565.10 | |
| Domain | HOLI | 5.22e-03 | 48 | 42 | 2 | SM00430 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 5.22e-03 | 48 | 42 | 2 | IPR000536 | |
| Domain | Hormone_recep | 5.22e-03 | 48 | 42 | 2 | PF00104 | |
| Domain | HMG_box | 6.33e-03 | 53 | 42 | 2 | PF00505 | |
| Domain | HMG_BOX_2 | 6.56e-03 | 54 | 42 | 2 | PS50118 | |
| Domain | HMG | 6.56e-03 | 54 | 42 | 2 | SM00398 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 7.86e-07 | 37 | 28 | 4 | M27797 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 1.77e-05 | 26 | 28 | 3 | MM14793 | |
| Pathway | PID_BETA_CATENIN_NUC_PATHWAY | 1.78e-05 | 80 | 28 | 4 | M223 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 2.48e-05 | 29 | 28 | 3 | M48076 | |
| Pathway | KEGG_THYROID_CANCER | 2.48e-05 | 29 | 28 | 3 | M523 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.95e-05 | 91 | 28 | 4 | M27101 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 3.50e-05 | 95 | 28 | 4 | M48268 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.03e-05 | 34 | 28 | 3 | MM15531 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 4.40e-05 | 35 | 28 | 3 | M47969 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 4.80e-05 | 36 | 28 | 3 | M633 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 7.65e-05 | 42 | 28 | 3 | M48237 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 8.77e-05 | 768 | 28 | 8 | MM14851 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.14e-04 | 48 | 28 | 3 | M611 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 1.37e-04 | 51 | 28 | 3 | M665 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.46e-04 | 137 | 28 | 4 | M48232 | |
| Pathway | PID_AR_TF_PATHWAY | 1.54e-04 | 53 | 28 | 3 | M151 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.70e-04 | 10 | 28 | 2 | MM15156 | |
| Pathway | REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS | 2.71e-04 | 161 | 28 | 4 | M27871 | |
| Pathway | WP_MECHANISMS_ASSOCIATED_WITH_PLURIPOTENCY | 2.82e-04 | 301 | 28 | 5 | MM15983 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 2.82e-04 | 65 | 28 | 3 | M39682 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 3.41e-04 | 14 | 28 | 2 | M27402 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.14e-04 | 74 | 28 | 3 | M616 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 4.83e-04 | 78 | 28 | 3 | M27234 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | 6.23e-04 | 1022 | 28 | 8 | MM15436 | |
| Pathway | WNT_SIGNALING | 7.11e-04 | 89 | 28 | 3 | M5493 | |
| Pathway | REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX | 8.34e-04 | 94 | 28 | 3 | M1041 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 8.57e-04 | 22 | 28 | 2 | MM1370 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | 9.13e-04 | 97 | 28 | 3 | M48262 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 9.38e-04 | 23 | 28 | 2 | MM1480 | |
| Pathway | BIOCARTA_HER2_PATHWAY | 9.38e-04 | 23 | 28 | 2 | M18719 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 1.02e-03 | 24 | 28 | 2 | M13404 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.03e-03 | 101 | 28 | 3 | MM15829 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 1.03e-03 | 1387 | 28 | 9 | M734 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 1.09e-03 | 233 | 28 | 4 | M27099 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 1.16e-03 | 237 | 28 | 4 | M27786 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 1.20e-03 | 26 | 28 | 2 | MM14878 | |
| Pathway | WP_THERMOGENESIS | 1.25e-03 | 108 | 28 | 3 | M39746 | |
| Pathway | REACTOME_TGFBR3_EXPRESSION | 1.39e-03 | 28 | 28 | 2 | M48253 | |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | 1.50e-03 | 254 | 28 | 4 | M27131 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 1.60e-03 | 30 | 28 | 2 | M207 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.71e-03 | 31 | 28 | 2 | M39522 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 1.82e-03 | 32 | 28 | 2 | MM14975 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.93e-03 | 272 | 28 | 4 | M29619 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4 | 1.93e-03 | 33 | 28 | 2 | M39455 | |
| Pathway | REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS | 1.99e-03 | 464 | 28 | 5 | M27547 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.56e-03 | 38 | 28 | 2 | M39657 | |
| Pathway | WP_NUCLEAR_RECEPTORS | 2.56e-03 | 38 | 28 | 2 | MM15865 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.73e-03 | 142 | 28 | 3 | M48257 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 2.83e-03 | 40 | 28 | 2 | MM14936 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.97e-03 | 41 | 28 | 2 | MM14876 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 3.12e-03 | 42 | 28 | 2 | M27272 | |
| Pathway | WP_MESODERMAL_COMMITMENT_PATHWAY | 3.37e-03 | 153 | 28 | 3 | M39546 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | 3.37e-03 | 153 | 28 | 3 | MM15522 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 3.67e-03 | 325 | 28 | 4 | M12868 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | 3.68e-03 | 158 | 28 | 3 | MM14791 | |
| Pathway | REACTOME_SIGNALING_BY_WNT | 3.87e-03 | 330 | 28 | 4 | M7847 | |
| Pathway | WP_RETT_SYNDROME | 4.06e-03 | 48 | 28 | 2 | M39759 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 4.06e-03 | 48 | 28 | 2 | MM14987 | |
| Pathway | REACTOME_SIGNALING_BY_TGFBR3 | 4.22e-03 | 49 | 28 | 2 | M48250 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 4.92e-03 | 53 | 28 | 2 | M8276 | |
| Pubmed | TCF4 SMG7 FUBP1 UBR4 YLPM1 SMARCA2 SMARCD2 R3HDM2 ZMIZ1 SSBP4 SSBP3 ARID1A RBM20 EP300 | 6.42e-09 | 1429 | 49 | 14 | 35140242 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 1.39e-08 | 457 | 49 | 9 | 32344865 | |
| Pubmed | TCF4 SMARCA2 SOX18 SMARCD2 ARID1A TCF7L1 NR2F1 RXRG MEIS1 RNF111 | 4.67e-08 | 709 | 49 | 10 | 22988430 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 3.06e-07 | 40 | 49 | 4 | 34585037 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 6.67e-07 | 220 | 49 | 6 | 35785414 | |
| Pubmed | Regulation of the CUL3Â Ubiquitin Ligase by a Calcium-Dependent Co-adaptor. | 7.63e-07 | 50 | 49 | 4 | 27716508 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | CDK8 SHROOM3 SMG7 FAM168A NACC2 JOSD2 FUBP1 SMARCA2 ZMIZ1 SSBP3 ARID1A EP300 | 7.68e-07 | 1489 | 49 | 12 | 28611215 |
| Pubmed | Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. | 9.46e-07 | 14 | 49 | 3 | 8895581 | |
| Pubmed | 1.12e-06 | 55 | 49 | 4 | 35945219 | ||
| Pubmed | 1.13e-06 | 130 | 49 | 5 | 19386638 | ||
| Pubmed | 1.17e-06 | 131 | 49 | 5 | 34551306 | ||
| Pubmed | 1.18e-06 | 15 | 49 | 3 | 11263494 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 1.18e-06 | 15 | 49 | 3 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 1.18e-06 | 15 | 49 | 3 | 17920018 | |
| Pubmed | 1.31e-06 | 134 | 49 | 5 | 19030180 | ||
| Pubmed | A human RNA polymerase II complex containing factors that modify chromatin structure. | 1.45e-06 | 16 | 49 | 3 | 9710619 | |
| Pubmed | Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma. | 1.45e-06 | 16 | 49 | 3 | 35390516 | |
| Pubmed | Widespread macromolecular interaction perturbations in human genetic disorders. | 1.60e-06 | 590 | 49 | 8 | 25910212 | |
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 1.76e-06 | 17 | 49 | 3 | 12368262 | |
| Pubmed | 1.76e-06 | 17 | 49 | 3 | 11078522 | ||
| Pubmed | 1.94e-06 | 2 | 49 | 2 | 11318604 | ||
| Pubmed | 2.11e-06 | 18 | 49 | 3 | 14559996 | ||
| Pubmed | TIF1gamma controls erythroid cell fate by regulating transcription elongation. | 2.11e-06 | 18 | 49 | 3 | 20603019 | |
| Pubmed | TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation. | 2.11e-06 | 18 | 49 | 3 | 28068325 | |
| Pubmed | BAF complexes facilitate decatenation of DNA by topoisomerase IIα. | 2.11e-06 | 18 | 49 | 3 | 23698369 | |
| Pubmed | 2.44e-06 | 152 | 49 | 5 | 38360978 | ||
| Pubmed | 2.51e-06 | 19 | 49 | 3 | 16932743 | ||
| Pubmed | Reciprocal regulation of CD4/CD8 expression by SWI/SNF-like BAF complexes. | 2.51e-06 | 19 | 49 | 3 | 12110891 | |
| Pubmed | 2.72e-06 | 634 | 49 | 8 | 34591612 | ||
| Pubmed | CDK8 AMBN ERBB4 SMG7 BAG4 SMARCA2 SMARCD2 ARID1A TCF7L1 EP300 | 2.93e-06 | 1116 | 49 | 10 | 31753913 | |
| Pubmed | 2.95e-06 | 20 | 49 | 3 | 11404013 | ||
| Pubmed | 4.21e-06 | 170 | 49 | 5 | 15057823 | ||
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 4.56e-06 | 23 | 49 | 3 | 30962207 | |
| Pubmed | Diversity and specialization of mammalian SWI/SNF complexes. | 4.56e-06 | 23 | 49 | 3 | 8804307 | |
| Pubmed | 5.21e-06 | 24 | 49 | 3 | 11790558 | ||
| Pubmed | Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. | 5.21e-06 | 24 | 49 | 3 | 10078207 | |
| Pubmed | 5.21e-06 | 24 | 49 | 3 | 12215535 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 36464671 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 17410209 | ||
| Pubmed | 5.83e-06 | 3 | 49 | 2 | 12079286 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 5.87e-06 | 704 | 49 | 8 | 29955894 | |
| Pubmed | 6.68e-06 | 26 | 49 | 3 | 10778858 | ||
| Pubmed | 7.51e-06 | 27 | 49 | 3 | 29374058 | ||
| Pubmed | 8.13e-06 | 90 | 49 | 4 | 33087562 | ||
| Pubmed | 8.40e-06 | 28 | 49 | 3 | 30037996 | ||
| Pubmed | REST repression of neuronal genes requires components of the hSWI.SNF complex. | 8.40e-06 | 28 | 49 | 3 | 12192000 | |
| Pubmed | 8.49e-06 | 91 | 49 | 4 | 21194568 | ||
| Pubmed | Control of developmentally primed erythroid genes by combinatorial co-repressor actions. | 1.04e-05 | 30 | 49 | 3 | 26593974 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 31906887 | ||
| Pubmed | Constitutional and functional genetics of human alcohol-related hepatocellular carcinoma. | 1.16e-05 | 4 | 49 | 2 | 28296015 | |
| Pubmed | C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin. | 1.16e-05 | 4 | 49 | 2 | 30986748 | |
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 33176148 | ||
| Pubmed | 1.16e-05 | 4 | 49 | 2 | 33481850 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.66e-05 | 582 | 49 | 7 | 20467437 | |
| Pubmed | 1.67e-05 | 35 | 49 | 3 | 32504627 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 18487222 | ||
| Pubmed | 1.94e-05 | 5 | 49 | 2 | 12200431 | ||
| Pubmed | 1.94e-05 | 396 | 49 | 6 | 26687479 | ||
| Pubmed | 1.97e-05 | 37 | 49 | 3 | 24335282 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 2.00e-05 | 398 | 49 | 6 | 35016035 | |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.39e-05 | 411 | 49 | 6 | 35182466 | |
| Pubmed | 2.88e-05 | 425 | 49 | 6 | 24999758 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 16940996 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 2.91e-05 | 6 | 49 | 2 | 25081545 | |
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 7947324 | ||
| Pubmed | 2.91e-05 | 6 | 49 | 2 | 26123998 | ||
| Pubmed | 3.46e-05 | 263 | 49 | 5 | 20932939 | ||
| Pubmed | 3.78e-05 | 268 | 49 | 5 | 33640491 | ||
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 16601680 | ||
| Pubmed | A switch from hBrm to Brg1 at IFNγ-activated sequences mediates the activation of human genes. | 4.07e-05 | 7 | 49 | 2 | 21079652 | |
| Pubmed | 4.07e-05 | 7 | 49 | 2 | 19303461 | ||
| Pubmed | 4.11e-05 | 453 | 49 | 6 | 29656893 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 12082103 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 21177349 | ||
| Pubmed | TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation. | 5.42e-05 | 8 | 49 | 2 | 32179550 | |
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 26986003 | ||
| Pubmed | 5.42e-05 | 8 | 49 | 2 | 32421711 | ||
| Pubmed | 6.96e-05 | 9 | 49 | 2 | 7823919 | ||
| Pubmed | 7.23e-05 | 157 | 49 | 4 | 30186101 | ||
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 7.71e-05 | 742 | 49 | 7 | 26871637 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 12665591 | ||
| Pubmed | HIF1A employs CDK8-mediator to stimulate RNAPII elongation in response to hypoxia. | 8.69e-05 | 10 | 49 | 2 | 23746844 | |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 8.69e-05 | 10 | 49 | 2 | 23129809 | |
| Pubmed | 8.69e-05 | 10 | 49 | 2 | 35210568 | ||
| Pubmed | 8.93e-05 | 61 | 49 | 3 | 20305087 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 15546612 | ||
| Pubmed | 1.06e-04 | 11 | 49 | 2 | 26965372 | ||
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 1.06e-04 | 11 | 49 | 2 | 25731772 | |
| Pubmed | PARP-1 determines specificity in a retinoid signaling pathway via direct modulation of mediator. | 1.06e-04 | 11 | 49 | 2 | 15808511 | |
| Pubmed | 1.08e-04 | 65 | 49 | 3 | 23453885 | ||
| Pubmed | 1.08e-04 | 65 | 49 | 3 | 26655900 | ||
| Pubmed | 1.13e-04 | 66 | 49 | 3 | 23275444 | ||
| Pubmed | Genome-scale study of transcription factor expression in the branching mouse lung. | 1.18e-04 | 67 | 49 | 3 | 22711520 | |
| Pubmed | TCF/Lef1-mediated control of lipid metabolism regulates skin barrier function. | 1.27e-04 | 12 | 49 | 2 | 21938009 | |
| Pubmed | Amelogenesis imperfecta in a new animal model--a mutation in chromosome 5 (human 4q21). | 1.27e-04 | 12 | 49 | 2 | 15271968 | |
| Pubmed | 1.27e-04 | 12 | 49 | 2 | 11734557 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 1.27e-04 | 12 | 49 | 2 | 11266540 | |
| Pubmed | 1.31e-04 | 808 | 49 | 7 | 20412781 | ||
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.35e-04 | 351 | 49 | 5 | 38297188 | |
| Interaction | CELF4 interactions | 5.29e-14 | 11 | 47 | 6 | int:CELF4 | |
| Interaction | ZNF683 interactions | 1.38e-11 | 10 | 47 | 5 | int:ZNF683 | |
| Interaction | PRR20B interactions | 3.14e-11 | 90 | 47 | 8 | int:PRR20B | |
| Interaction | PRR20C interactions | 3.14e-11 | 90 | 47 | 8 | int:PRR20C | |
| Interaction | PRR20D interactions | 3.14e-11 | 90 | 47 | 8 | int:PRR20D | |
| Interaction | VPS37C interactions | 3.38e-11 | 141 | 47 | 9 | int:VPS37C | |
| Interaction | FAM168A interactions | PRR20C PRR20D PRR20B FAM168A PRR20E PRR20A SMARCD2 R3HDM2 TFG | 3.60e-11 | 142 | 47 | 9 | int:FAM168A |
| Interaction | BEND2 interactions | 4.33e-11 | 12 | 47 | 5 | int:BEND2 | |
| Interaction | TLX3 interactions | PRR20C PRR20D PRR20B PRR20E TLE2 SMARCA2 PRR20A SSBP3 ARID1A EP300 MEIS1 | 5.17e-11 | 291 | 47 | 11 | int:TLX3 |
| Interaction | PRR20E interactions | 8.03e-11 | 101 | 47 | 8 | int:PRR20E | |
| Interaction | PTTG2 interactions | 1.09e-10 | 14 | 47 | 5 | int:PTTG2 | |
| Interaction | PRR20A interactions | 1.49e-10 | 109 | 47 | 8 | int:PRR20A | |
| Interaction | LASP1 interactions | TCF4 PRR20C PRR20D PRR20B FAM168A PRR20E BAG4 PRR20A TFG EP300 | 2.22e-10 | 247 | 47 | 10 | int:LASP1 |
| Interaction | MBNL3 interactions | 2.37e-10 | 16 | 47 | 5 | int:MBNL3 | |
| Interaction | HLX interactions | 2.54e-10 | 37 | 47 | 6 | int:HLX | |
| Interaction | FAM222B interactions | 5.69e-10 | 42 | 47 | 6 | int:FAM222B | |
| Interaction | BICRAL interactions | 6.60e-10 | 43 | 47 | 6 | int:BICRAL | |
| Interaction | RBPMS2 interactions | 8.55e-10 | 83 | 47 | 7 | int:RBPMS2 | |
| Interaction | PRR34 interactions | 1.10e-09 | 21 | 47 | 5 | int:PRR34 | |
| Interaction | TPRX1 interactions | 1.10e-09 | 21 | 47 | 5 | int:TPRX1 | |
| Interaction | KRTAP19-1 interactions | 1.15e-09 | 47 | 47 | 6 | int:KRTAP19-1 | |
| Interaction | OXER1 interactions | 1.70e-09 | 50 | 47 | 6 | int:OXER1 | |
| Interaction | SS18L1 interactions | 2.78e-09 | 98 | 47 | 7 | int:SS18L1 | |
| Interaction | RIPPLY1 interactions | 3.07e-09 | 55 | 47 | 6 | int:RIPPLY1 | |
| Interaction | C3orf36 interactions | 3.51e-09 | 26 | 47 | 5 | int:C3orf36 | |
| Interaction | C1orf94 interactions | 3.94e-09 | 103 | 47 | 7 | int:C1orf94 | |
| Interaction | TIAL1 interactions | 5.66e-09 | 172 | 47 | 8 | int:TIAL1 | |
| Interaction | FOXH1 interactions | 5.86e-09 | 109 | 47 | 7 | int:FOXH1 | |
| Interaction | TFG interactions | PRR20C PRR20D PRR20B FAM168A PRR20E ANXA11 PRR20A R3HDM2 TFG | 7.16e-09 | 258 | 47 | 9 | int:TFG |
| Interaction | C10orf55 interactions | 8.61e-09 | 65 | 47 | 6 | int:C10orf55 | |
| Interaction | DAZAP2 interactions | 1.05e-08 | 186 | 47 | 8 | int:DAZAP2 | |
| Interaction | TBX3 interactions | 1.24e-08 | 69 | 47 | 6 | int:TBX3 | |
| Interaction | ZNF385C interactions | 1.25e-08 | 33 | 47 | 5 | int:ZNF385C | |
| Interaction | PITX1 interactions | 1.70e-08 | 127 | 47 | 7 | int:PITX1 | |
| Interaction | ZCCHC14 interactions | 2.28e-08 | 37 | 47 | 5 | int:ZCCHC14 | |
| Interaction | MAGED1 interactions | 2.29e-08 | 295 | 47 | 9 | int:MAGED1 | |
| Interaction | ESRP1 interactions | 2.42e-08 | 77 | 47 | 6 | int:ESRP1 | |
| Interaction | NR4A1 interactions | 2.90e-08 | 212 | 47 | 8 | int:NR4A1 | |
| Interaction | SP7 interactions | 2.96e-08 | 304 | 47 | 9 | int:SP7 | |
| Interaction | TBX6 interactions | 3.90e-08 | 41 | 47 | 5 | int:TBX6 | |
| Interaction | FOXP3 interactions | PRR20C PRR20D PRR20B SEC24C NACC2 PRR20E PRR20A SSBP3 ARID1A EP300 | 4.71e-08 | 432 | 47 | 10 | int:FOXP3 |
| Interaction | SAMD11 interactions | 4.99e-08 | 43 | 47 | 5 | int:SAMD11 | |
| Interaction | DMRT3 interactions | 5.06e-08 | 87 | 47 | 6 | int:DMRT3 | |
| Interaction | SP4 interactions | 7.07e-08 | 46 | 47 | 5 | int:SP4 | |
| Interaction | RBPMS interactions | 7.72e-08 | 340 | 47 | 9 | int:RBPMS | |
| Interaction | RBM23 interactions | 8.06e-08 | 94 | 47 | 6 | int:RBM23 | |
| Interaction | SMARCC2 interactions | 1.06e-07 | 353 | 47 | 9 | int:SMARCC2 | |
| Interaction | KRTAP19-5 interactions | 1.10e-07 | 99 | 47 | 6 | int:KRTAP19-5 | |
| Interaction | TOLLIP interactions | 1.20e-07 | 358 | 47 | 9 | int:TOLLIP | |
| Interaction | RHOXF2 interactions | 1.48e-07 | 104 | 47 | 6 | int:RHOXF2 | |
| Interaction | VENTX interactions | 1.48e-07 | 104 | 47 | 6 | int:VENTX | |
| Interaction | NCK2 interactions | 1.49e-07 | 262 | 47 | 8 | int:NCK2 | |
| Interaction | SH3RF1 interactions | 1.85e-07 | 108 | 47 | 6 | int:SH3RF1 | |
| Interaction | ZBTB32 interactions | 2.32e-07 | 58 | 47 | 5 | int:ZBTB32 | |
| Interaction | HIVEP1 interactions | 2.35e-07 | 186 | 47 | 7 | int:HIVEP1 | |
| Interaction | TBR1 interactions | 2.42e-07 | 113 | 47 | 6 | int:TBR1 | |
| Interaction | FAM9A interactions | 2.53e-07 | 59 | 47 | 5 | int:FAM9A | |
| Interaction | CABP2 interactions | 2.99e-07 | 61 | 47 | 5 | int:CABP2 | |
| Interaction | ETS1 interactions | 3.63e-07 | 121 | 47 | 6 | int:ETS1 | |
| Interaction | EIF4ENIF1 interactions | 4.17e-07 | 300 | 47 | 8 | int:EIF4ENIF1 | |
| Interaction | PAX7 interactions | 4.20e-07 | 124 | 47 | 6 | int:PAX7 | |
| Interaction | PDCD6 interactions | 4.38e-07 | 204 | 47 | 7 | int:PDCD6 | |
| Interaction | SMAP1 interactions | 4.80e-07 | 67 | 47 | 5 | int:SMAP1 | |
| Interaction | NUP35 interactions | 4.98e-07 | 424 | 47 | 9 | int:NUP35 | |
| Interaction | ETV4 interactions | 5.57e-07 | 69 | 47 | 5 | int:ETV4 | |
| Interaction | SNRPC interactions | 6.78e-07 | 440 | 47 | 9 | int:SNRPC | |
| Interaction | ARID5A interactions | 1.14e-06 | 147 | 47 | 6 | int:ARID5A | |
| Interaction | SOX7 interactions | 1.32e-06 | 82 | 47 | 5 | int:SOX7 | |
| Interaction | PRR35 interactions | 1.40e-06 | 83 | 47 | 5 | int:PRR35 | |
| Interaction | PATZ1 interactions | 2.08e-06 | 163 | 47 | 6 | int:PATZ1 | |
| Interaction | TLE3 interactions | 2.27e-06 | 376 | 47 | 8 | int:TLE3 | |
| Interaction | LHX4 interactions | 2.32e-06 | 166 | 47 | 6 | int:LHX4 | |
| Interaction | DPF3 interactions | 2.75e-06 | 95 | 47 | 5 | int:DPF3 | |
| Interaction | TLX1 interactions | 3.14e-06 | 175 | 47 | 6 | int:TLX1 | |
| Interaction | POU2F1 interactions | 3.14e-06 | 175 | 47 | 6 | int:POU2F1 | |
| Interaction | NFYC interactions | 3.36e-06 | 177 | 47 | 6 | int:NFYC | |
| Interaction | RARB interactions | 3.94e-06 | 46 | 47 | 4 | int:RARB | |
| Interaction | ALG13 interactions | 4.07e-06 | 183 | 47 | 6 | int:ALG13 | |
| Interaction | TCF7L2 interactions | 4.07e-06 | 285 | 47 | 7 | int:TCF7L2 | |
| Interaction | LHX1 interactions | 4.09e-06 | 103 | 47 | 5 | int:LHX1 | |
| Interaction | TRIM35 interactions | 4.09e-06 | 103 | 47 | 5 | int:TRIM35 | |
| Interaction | ABI2 interactions | 4.17e-06 | 286 | 47 | 7 | int:ABI2 | |
| Interaction | GTF2A1 interactions | 4.29e-06 | 104 | 47 | 5 | int:GTF2A1 | |
| Interaction | VEZF1 interactions | 4.50e-06 | 105 | 47 | 5 | int:VEZF1 | |
| Interaction | GATA3 interactions | 4.61e-06 | 187 | 47 | 6 | int:GATA3 | |
| Interaction | GLIS2 interactions | 4.71e-06 | 106 | 47 | 5 | int:GLIS2 | |
| Interaction | PAX8 interactions | 5.91e-06 | 111 | 47 | 5 | int:PAX8 | |
| Interaction | NOTCH3 interactions | 6.45e-06 | 113 | 47 | 5 | int:NOTCH3 | |
| Interaction | GATA2 interactions | 6.59e-06 | 199 | 47 | 6 | int:GATA2 | |
| Interaction | VAC14 interactions | 6.98e-06 | 201 | 47 | 6 | int:VAC14 | |
| Interaction | LHX8 interactions | 6.99e-06 | 53 | 47 | 4 | int:LHX8 | |
| Interaction | TBXT interactions | 7.33e-06 | 116 | 47 | 5 | int:TBXT | |
| Interaction | CIITA interactions | 8.12e-06 | 55 | 47 | 4 | int:CIITA | |
| Interaction | BHLHE40 interactions | 8.30e-06 | 119 | 47 | 5 | int:BHLHE40 | |
| Interaction | THAP1 interactions | 8.30e-06 | 119 | 47 | 5 | int:THAP1 | |
| Interaction | ANKHD1 interactions | 1.05e-05 | 216 | 47 | 6 | int:ANKHD1 | |
| Interaction | HYPK interactions | 1.05e-05 | 125 | 47 | 5 | int:HYPK | |
| Interaction | RBM42 interactions | 1.08e-05 | 331 | 47 | 7 | int:RBM42 | |
| Interaction | ERG interactions | 1.26e-05 | 223 | 47 | 6 | int:ERG | |
| Interaction | SIAH1 interactions | 1.26e-05 | 223 | 47 | 6 | int:SIAH1 | |
| Cytoband | 13q21.1 | 1.44e-12 | 13 | 49 | 5 | 13q21.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr13q21 | 1.72e-07 | 117 | 49 | 5 | chr13q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr10q22 | 1.45e-03 | 208 | 49 | 3 | chr10q22 | |
| GeneFamily | Nuclear hormone receptors | 2.60e-03 | 49 | 28 | 2 | 71 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | FUBP1 SMARCA2 NAV2 R3HDM2 ZMIZ1 ARID1A TCF7L1 RBM20 RXRG MEIS1 | 6.39e-06 | 1009 | 45 | 10 | M157 |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.40e-06 | 187 | 46 | 5 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-06 | 190 | 46 | 5 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 1.60e-06 | 192 | 46 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.60e-06 | 192 | 46 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-INs|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.77e-06 | 196 | 46 | 5 | 556e18eae05bf19259fe02848bcc9120aa2a9d29 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.81e-06 | 197 | 46 | 5 | ad6c200a193a15360d17463e18a465ce1b90b8da | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.86e-06 | 198 | 46 | 5 | 076c862f2a723f0361749377561cae902068b1a0 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-Neuronal-GABAergic_neurons|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.95e-06 | 200 | 46 | 5 | bad32a95b759fad509401b07bc96a56687c2a592 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19-Neuronal-GABAergic_neurons|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-06 | 88 | 46 | 4 | 5582fd7bac60c690ecd1f2aff1d446ccb69f79b9 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lmo1_Myl1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-05 | 145 | 46 | 4 | 590ba937c741ae67460f303eca88b1cd3ac87f64 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 2.71e-05 | 168 | 46 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 170 | 46 | 4 | fa753cc8fbd04e63c9a303da4dc17ee2ce907f92 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.84e-05 | 170 | 46 | 4 | 03044e1436443b28dd39d5ef4fdb25c18e3a7546 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.84e-05 | 170 | 46 | 4 | 6c65ddb496030bb479ef346cc37a9d4dfa6b824f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 172 | 46 | 4 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-05 | 172 | 46 | 4 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-05 | 175 | 46 | 4 | 1b4cefae400bf756d09ece32d3f5c0bd4c6ad73f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_2-Inh_L3-6_PVALB_MFI2_(Chandelier_2)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.39e-05 | 178 | 46 | 4 | c982a73955c9c193bcab21d60d453afcc09cd586 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 181 | 46 | 4 | a2058d658f07ab6f0a28d2622f3090b4cde6f763 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.62e-05 | 181 | 46 | 4 | 526e858a848470b6d2d5248788004d9735ed3add | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 182 | 46 | 4 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 182 | 46 | 4 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Neuronal-Interneuron|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 3.80e-05 | 63 | 46 | 3 | c10d344bf32a091deb79e1f128f7dd5e9f4abaa3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 184 | 46 | 4 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.86e-05 | 184 | 46 | 4 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 4.20e-05 | 188 | 46 | 4 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.20e-05 | 188 | 46 | 4 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 4.20e-05 | 188 | 46 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | COVID-19-kidney-DCT|kidney / Disease (COVID-19 only), tissue and cell type | 4.20e-05 | 188 | 46 | 4 | df1fd0819d301679f3c9ea404e942e39095912eb | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.29e-05 | 189 | 46 | 4 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 191 | 46 | 4 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.47e-05 | 191 | 46 | 4 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 4.47e-05 | 191 | 46 | 4 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.47e-05 | 191 | 46 | 4 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.56e-05 | 192 | 46 | 4 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 4.56e-05 | 192 | 46 | 4 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.56e-05 | 192 | 46 | 4 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 46 | 4 | 61c2caf6c838132ed5faa8791c288f2149eba2c8 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-05 | 192 | 46 | 4 | e19e3e8edcc08e4a67873bfb6e46489ca6c8756a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.65e-05 | 193 | 46 | 4 | 09a9ab029f01234459a88e3e994fe90ef4cbb8c6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.65e-05 | 193 | 46 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.75e-05 | 194 | 46 | 4 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 4.75e-05 | 194 | 46 | 4 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 4.75e-05 | 194 | 46 | 4 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-05 | 194 | 46 | 4 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.75e-05 | 194 | 46 | 4 | c49f72441b3557e2c3a9c4239e68c0cf0652814b | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.75e-05 | 194 | 46 | 4 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-05 | 195 | 46 | 4 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Control-Multiplet|Control / Disease state, Lineage and Cell class | 4.84e-05 | 195 | 46 | 4 | 618900c80bea09d46dad3f741bd1bff8bf0a64ee | |
| ToppCell | Control-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class | 4.84e-05 | 195 | 46 | 4 | 06ac685855e14e4dd2cbe6d0e73f894f2eeff91f | |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.84e-05 | 195 | 46 | 4 | 9406866f99555198a9be311fbd65751b70f35446 | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.84e-05 | 195 | 46 | 4 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 4.84e-05 | 195 | 46 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 5.04e-05 | 197 | 46 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 5.04e-05 | 197 | 46 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.04e-05 | 197 | 46 | 4 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_Interneurons|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 5.14e-05 | 198 | 46 | 4 | 5798640425cabf4ac517b7f96a9dfd32f6e5e7c5 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-05 | 198 | 46 | 4 | f948391296c261c473d339069a6d0f20ccd6f38f | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 5.24e-05 | 199 | 46 | 4 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|kidney / Disease (COVID-19 only), tissue and cell type | 5.24e-05 | 199 | 46 | 4 | 9503646ff1ad248181146ce767e9d12e882ec3bd | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | e16bde12326f0cfc4d03f9307cba0e21ea2389cb | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Interneuron|6m / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | 274871d632bbbe03720726a59ab3ec6d5fa0da11 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.34e-05 | 200 | 46 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 5.34e-05 | 200 | 46 | 4 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.34e-05 | 200 | 46 | 4 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuronal-Interneuron|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 2.65e-04 | 121 | 46 | 3 | b2d571f571133c281d72584fe925cebbd2317829 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Tmem182|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.27e-04 | 130 | 46 | 3 | 8bd038b0423960ffdc6c8b128c46a55386f9c58c | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 4.06e-04 | 140 | 46 | 3 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | Control-NK|World / Disease group and Cell class | 4.32e-04 | 143 | 46 | 3 | fe08adc9472dfd4242497d6c614d0490713261da | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 4.77e-04 | 148 | 46 | 3 | db046a02a00829910bf9d7dbda068e730aa78f00 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_Invariant-Inducer-like-ILC3|bone_marrow / Manually curated celltypes from each tissue | 4.87e-04 | 149 | 46 | 3 | d7f1069f70f3cad6d3700ee2041ed1d4cb7c49ab | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.87e-04 | 149 | 46 | 3 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-04 | 152 | 46 | 3 | acfafdb64bd5b0eb7371b04cfef51ed2798e9b30 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-common_lymphoid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-04 | 152 | 46 | 3 | 9d6c88ceca0569dbeb12e488acec7fcb7f972f03 | |
| ToppCell | 390C-Myeloid-Macrophage-SPP1+_Macrophage_2|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.46e-04 | 155 | 46 | 3 | 15bacd06cc2b02b13c85bb71c5b758e5ff613e80 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 5.56e-04 | 156 | 46 | 3 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-04 | 159 | 46 | 3 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.88e-04 | 159 | 46 | 3 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.10e-04 | 161 | 46 | 3 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-04 | 161 | 46 | 3 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-04 | 162 | 46 | 3 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | droplet-Marrow-BM-30m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.21e-04 | 162 | 46 | 3 | 75df7ff779a3b9159ba97d852da1f8df650b9ce5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.21e-04 | 162 | 46 | 3 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.21e-04 | 162 | 46 | 3 | 5c9bc3c3857a99d8a3caf359a7eb279ce9cc1c81 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal-GABAergic_neurons|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 6.43e-04 | 164 | 46 | 3 | 4d7b2d0980fb4f47721fa2891151e2bd892ccb91 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.43e-04 | 164 | 46 | 3 | f6a961fa2002da7d9679f32af99e1314c0593ef9 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 6.66e-04 | 166 | 46 | 3 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 6.78e-04 | 167 | 46 | 3 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 6.78e-04 | 167 | 46 | 3 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231|Adult / Lineage, Cell type, age group and donor | 6.78e-04 | 167 | 46 | 3 | 5af9127bae05768a5164d5708a4ad37edca99324 | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 6.78e-04 | 167 | 46 | 3 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | Control-NK|Control / Disease group and Cell class | 6.90e-04 | 168 | 46 | 3 | 683d389c8a1e791bfc773e63148115a21a6566db | |
| ToppCell | AT1-AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.02e-04 | 169 | 46 | 3 | 815474855a70498a74e52f6583113c63b7267a0c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.02e-04 | 169 | 46 | 3 | cd16e8462ee09877be962fbd9a3badcb825820b0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.02e-04 | 169 | 46 | 3 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 7.14e-04 | 170 | 46 | 3 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 7.14e-04 | 170 | 46 | 3 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1_VIP_PCDH20|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.39e-04 | 172 | 46 | 3 | 35e961c88bfe79046533396912cedf00ca81db7b | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 2.42e-06 | 193 | 46 | 6 | 4426_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 3.08e-05 | 180 | 46 | 5 | 4541_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.42e-05 | 184 | 46 | 5 | 1064_DN | |
| Drug | Chrysene-1,4-quinone [100900-16-1]; Down 200; 15.4uM; HL60; HG-U133A | 4.30e-05 | 193 | 46 | 5 | 1773_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.30e-05 | 193 | 46 | 5 | 6967_DN | |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; HL60; HG-U133A | 4.40e-05 | 194 | 46 | 5 | 1424_DN | |
| Drug | Scoulerine [6451-73-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 4.62e-05 | 196 | 46 | 5 | 5111_DN | |
| Drug | Streptozotocin [18883-66-4]; Down 200; 15uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 7193_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.85e-05 | 198 | 46 | 5 | 1070_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 4.85e-05 | 198 | 46 | 5 | 6930_UP | |
| Disease | obsolete aging, cognition | 3.04e-11 | 15 | 49 | 5 | EFO_0003925, GO_0007568 | |
| Disease | irritable bowel syndrome | 8.16e-08 | 131 | 49 | 6 | EFO_0000555 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 8.48e-08 | 66 | 49 | 5 | EFO_0007708 | |
| Disease | mosaic loss of chromosome Y measurement | 2.24e-07 | 80 | 49 | 5 | EFO_0007783 | |
| Disease | Tinnitus, wellbeing measurement | 5.59e-07 | 96 | 49 | 5 | EFO_0007869, HP_0000360 | |
| Disease | feeling "fed-up" measurement | 7.88e-06 | 76 | 49 | 4 | EFO_0009588 | |
| Disease | telomere length | 1.29e-05 | 313 | 49 | 6 | EFO_0004505 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.80e-05 | 195 | 49 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | electrocardiography | 2.59e-05 | 530 | 49 | 7 | EFO_0004327 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 2.69e-05 | 5 | 49 | 2 | C3281201 | |
| Disease | neuroticism measurement, cognitive function measurement | 3.94e-05 | 566 | 49 | 7 | EFO_0007660, EFO_0008354 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 4.39e-05 | 41 | 49 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 4.39e-05 | 41 | 49 | 3 | C0858252 | |
| Disease | occupational attainment | 4.72e-05 | 42 | 49 | 3 | EFO_0020977 | |
| Disease | childhood gender nonconformity | 5.07e-05 | 43 | 49 | 3 | EFO_0020103 | |
| Disease | age at menarche | 5.34e-05 | 594 | 49 | 7 | EFO_0004703 | |
| Disease | Malignant neoplasm of breast | 6.00e-05 | 1074 | 49 | 9 | C0006142 | |
| Disease | mood instability measurement | 6.15e-05 | 128 | 49 | 4 | EFO_0008475 | |
| Disease | apolipoprotein A 1 measurement | 7.15e-05 | 848 | 49 | 8 | EFO_0004614 | |
| Disease | unipolar depression, mood disorder | 7.35e-05 | 134 | 49 | 4 | EFO_0003761, EFO_0004247 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 9.65e-05 | 9 | 49 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | glucagon-like peptide-1 measurement | 1.21e-04 | 10 | 49 | 2 | EFO_0008465 | |
| Disease | major depressive disorder | 1.29e-04 | 155 | 49 | 4 | MONDO_0002009 | |
| Disease | coffee consumption measurement, neuroticism measurement | 1.91e-04 | 67 | 49 | 3 | EFO_0006781, EFO_0007660 | |
| Disease | Coffin-Siris syndrome | 2.08e-04 | 13 | 49 | 2 | C0265338 | |
| Disease | chronic obstructive pulmonary disease, surfactant protein D measurement | 2.08e-04 | 13 | 49 | 2 | EFO_0000341, EFO_0005081 | |
| Disease | T-Cell Lymphoma | 3.19e-04 | 16 | 49 | 2 | C0079772 | |
| Disease | nervousness | 3.19e-04 | 16 | 49 | 2 | NCIT_C74532 | |
| Disease | atrial fibrillation | 3.70e-04 | 371 | 49 | 5 | EFO_0000275 | |
| Disease | Feeding difficulties | 4.06e-04 | 18 | 49 | 2 | C0232466 | |
| Disease | Adenocarcinoma of large intestine | 5.52e-04 | 96 | 49 | 3 | C1319315 | |
| Disease | Adenoid Cystic Carcinoma | 6.21e-04 | 100 | 49 | 3 | C0010606 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 6.40e-04 | 101 | 49 | 3 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | neurotic disorder | 6.40e-04 | 101 | 49 | 3 | EFO_0004257 | |
| Disease | gastroesophageal reflux disease | 6.40e-04 | 101 | 49 | 3 | EFO_0003948 | |
| Disease | depressive symptom measurement | 6.93e-04 | 426 | 49 | 5 | EFO_0007006 | |
| Disease | glycerol measurement | 8.56e-04 | 26 | 49 | 2 | EFO_0010115 | |
| Disease | vital capacity | 9.05e-04 | 1236 | 49 | 8 | EFO_0004312 | |
| Disease | unipolar depression, irritable bowel syndrome | 9.93e-04 | 28 | 49 | 2 | EFO_0000555, EFO_0003761 | |
| Disease | self rated health | 1.22e-03 | 31 | 49 | 2 | EFO_0004778 | |
| Disease | parental longevity | 1.34e-03 | 494 | 49 | 5 | EFO_0007796 | |
| Disease | monocyte count | 1.38e-03 | 1320 | 49 | 8 | EFO_0005091 | |
| Disease | household income | 1.63e-03 | 304 | 49 | 4 | EFO_0009695 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RGQVPGYPPSQNPGM | 201 | O95429 | |
| SPPPAYTPMSGNQFV | 1051 | Q15303 | |
| NPPMGYGPRMQQPSN | 746 | Q09472 | |
| NSMPPYLPRTQAAGP | 1881 | Q09472 | |
| GQPPSAQQPVPPYGM | 91 | P50995 | |
| RPPPGTQGMLEQYLN | 36 | P59052 | |
| HGPMPQNKQSPLYPG | 226 | Q9NP70 | |
| TMYNNGGIPLPLTPQ | 521 | O75185 | |
| PPGSEQYQMPQSPSP | 671 | Q9Y2K5 | |
| FSPPSQTRGPGPSMN | 171 | Q5T481 | |
| MPPTQPNPGQYALTN | 161 | P10589 | |
| YGPAPSTRPMGPQAA | 1051 | Q9H3S7 | |
| AVSQGTPYNPDGQPM | 341 | O00470 | |
| GNQMPPRPPSGQSDS | 721 | O14497 | |
| NPQMPQYSSPQPGSA | 756 | O14497 | |
| MQRQNFRPPTPPYPG | 1 | Q8TAP9 | |
| SPVQPGAPYGNPKNM | 6 | Q92567 | |
| YAQTSPQGMPQHPPA | 626 | Q96AE4 | |
| QDPYRGMPPGLQGQS | 491 | P15884 | |
| MSQAPGAQPSPPTVY | 1 | Q8TAC2 | |
| PQYSTARMTPPPGPQ | 3061 | Q9Y6V0 | |
| QYPGQANRTAPGPML | 91 | P09131 | |
| RSMAPNQASGGPPPE | 11 | P86480 | |
| RSMAPNQASGGPPPE | 11 | P86496 | |
| RSMAPNQASGGPPPE | 11 | P86481 | |
| NGSSQMPGNPPRLPF | 191 | Q96RP8 | |
| PNDYQSSRNQPGPPG | 2931 | Q99715 | |
| YPNPGPSTSQPQSSM | 431 | P49336 | |
| GPVPGYQQTPPQGMS | 46 | P53992 | |
| YQQTPPQGMSRAPPS | 51 | P53992 | |
| PQNYGSGMRPPPNSL | 216 | Q9BWW4 | |
| PQAMSQPNRGPSPFS | 161 | P51531 | |
| RSMAPNQASGGPPPE | 11 | P86479 | |
| IPYSQQRPSGPGPMN | 716 | Q92540 | |
| PSMGNGYPPRANASR | 821 | Q8IVL1 | |
| RSMAPNQASGGPPPE | 11 | P86478 | |
| GQTGRQPLPPYTPAM | 1371 | Q8TF72 | |
| GPAAQYQRPGMSPGN | 66 | Q92925 | |
| YGQISQAFPQPPPMI | 396 | Q9BZC1 | |
| PSPMPYTQRAAGPGT | 326 | Q96F05 | |
| YGSSMVAQPQPQPPP | 621 | Q6ZNA4 | |
| LVPQQGQPMYSLPPG | 251 | Q9HCS4 | |
| QPGMAPSQPGAYQPR | 346 | Q92734 | |
| MTPPPSGPNPYARNR | 371 | Q92734 | |
| PSNMPSGNYTGIQIP | 201 | Q9NP79 | |
| PQSYGGGMRPPPNSL | 211 | Q9BWG4 | |
| PGLPGIGNMNYPSTS | 116 | P48443 | |
| LQNTSSRPGMYPPPG | 1496 | P49750 | |
| MQRSPPGYGAQDDPP | 1 | P35713 | |
| RMPGNPYSSNEPGIG | 4366 | Q5T4S7 | |
| MYPQGRHPTPLQSGQ | 1 | Q04725 | |
| HGQRMPQQTYPGPRP | 381 | Q9ULJ6 | |
| TSPNYPGQRMPSQPS | 441 | Q9ULJ6 | |
| PGQRMPSQPSSGQYP | 446 | Q9ULJ6 | |
| IQQMPYPQGERTSPG | 236 | Q96BF6 |